RCM Technologies, Inc. (RCMT) KPIs and segments
Close on Nov 12, 2026Market cap $223.70MP/E 13.2Yield –
KPIs & segments
Operating metrics and segments that drive RCM Technologies's business
RCM Technologies's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Specialty Health Care($M) | 44.7 | 48.1 | 48.0 | 30 | 42.8 | 43.3 | 41.0 | 26.6 | 36.9 | 38.2 | 36.7 | 24.9 | |
Engineering($M) | 39.5 | 26.1 | 30.4 | 31.4 | 26.5 | 32.1 | 26.3 | 24.2 | 22.5 | 23.5 | 22.7 | 22.5 | |
Life Sciences, Data & Solutions($M) | 9.56 | 8.80 | 8.07 | 8.87 | 8.82 | 9.05 | 9.62 | 9.64 | 9.72 | 10.3 | |||
Corporate Segment($M) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Earlier reporting (last reported 2024)1 | |||||||||||||
Health Care($M) | 44.7 | 48.1 | 48 | 30.0 | 42.8 | 43.3 | 41.0 | 26.6 | 36.9 | 38.2 | 36.7 | 24.9 | |
Engineering Services($M) | 39.5 | 26.1 | 30.4 | 31.4 | 26.5 | 32.1 | 26.3 | 24.2 | 22.5 | 23.5 | 22.7 | 22.5 | |
Technology Service($M) | 9.56 | 8.80 | 8.07 | 8.88 | 8.82 | 9.05 | 9.62 | 9.64 | 9.72 | 10.3 | 11.6 | 10.7 | |
US($M) | 88.1 | 77.7 | 76.7 | 61.4 | 73.2 | 78.8 | 71.0 | 55.3 | 63.6 | 66.9 | 66.8 | 53.7 | |
Europe($M) | 2.80 | 2.23 | 6.11 | 5.64 | 1.45 | 2.11 | 2.25 | 1.58 | 1.96 | 1.62 | 1.06 | 1.08 | |
Puerto Rico($M) | 1.66 | 1.76 | 1.69 | 1.52 | 1.54 | 1.61 | 1.43 | 1.57 | 2.02 | 2.00 | 1.77 | 1.64 | |
Canada($M) | 1.21 | 1.30 | 1.93 | 1.75 | 1.94 | 1.92 | 2.21 | 1.90 | 1.62 | 1.47 | 1.42 | 1.65 | |
Philippines($M) | 0 | 0 | 0 | 0 | |||||||||
Specialty Health Care($M) | 6.42 | 6.64 | 7.84 | 2.70 | 6.08 | 6.17 | 5.92 | 3.23 | 5.26 | 3.48 | 4.10 | 1.39 | |
Engineering($M) | 3.67 | 2.38 | 4.69 | 3.75 | 3.32 | 2.88 | 1.83 | 2.85 | 2.98 | 1.18 | 1.66 | 1.16 | |
Life Sciences, Data & Solutions($M) | 2.69 | 2.05 | 0.15 | 2.06 | 1.98 | 2.12 | 3.53 | 1.93 | 1.60 | 1.17 | |||
Corporate Segment($M) | -4.82 | -5.12 | -4.70 | -4.58 | -4.77 | -4.60 | -4.99 | -3.63 | -4.01 | 0 | 0 | 0 | |
Earlier reporting (last reported 2024)1 | |||||||||||||
Specialty Health Care($M) | 13.2 | 13.4 | 13.9 | 8.99 | 12.3 | 12.2 | 12.5 | 8.28 | 10.6 | 11.1 | 11.0 | 7.46 | |
Engineering($M) | 7.04 | 5.30 | 7.80 | 6.91 | 6.49 | 6.19 | 5.18 | 5.89 | 5.97 | 5.50 | 6.13 | 5.61 | |
Life Sciences, Data & Solutions($M) | 3.88 | 3.28 | 2.55 | 3.51 | 3.51 | 3.59 | 3.85 | 3.66 | 3.40 | 3.79 | |||
Corporate Segment($M) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Earlier reporting (last reported 2024)1 | |||||||||||||
Life Sciences, Data & Solutions($M) | 0 | 0 | -0.00 | 0 | 0.00 | -0.05 | -0.01 | 0 | -0.01 | -0.01 | |||
Corporate Segment($M) | -0.01 | -0.02 | -0.05 | -0.29 | -0.23 | -0.27 | -0.85 | -0.08 | -0.29 | -0.35 | -1.91 | -0.02 | |
Engineering($M) | -0.04 | -0.04 | -0.10 | -0.14 | -0.18 | -0.07 | -0.07 | -0.38 | -0.05 | -0.20 | -0.08 | -0.16 | |
Specialty Health Care($M) | -0.05 | -0.03 | -0.04 | -0.07 | -0.08 | -0.04 | -0.06 | -0.07 | -0.06 | -0.11 | -0.03 | -0.06 | |
Earlier reporting (last reported 2024)1 | |||||||||||||
Engineering($M) | 64.0 | 64.3 | 60.6 | 56.3 | 58.3 | 47.5 | 52.2 | 52.3 | 47.4 | 50.6 | 46.4 | 45.9 | |
Specialty Health Care($M) | 40.9 | 45.0 | 46.5 | 48.0 | 48.2 | 16.1 | 43.2 | 40.5 | 40.2 | 43.7 | 43.8 | 32.3 | |
Corporate Segment($M) | 14.8 | 12.6 | 13.4 | 8.57 | 12.6 | 13.2 | 14.5 | 11.0 | 10.3 | 7.83 | 11.7 | 5.33 | |
Life Sciences, Data & Solutions($M) | 14.3 | 13.5 | 13.9 | 16.9 | 16.5 | 44.2 | 22.2 | 21.7 | 20.4 | 18.4 | 18.6 | ||
Earlier reporting (last reported 2024)1 | |||||||||||||
US($M) | 119 | 123 | 123 | 121 | 126 | 113 | 124 | 114 | 110 | 114 | 111 | 91.1 | |
Europe($M) | 10.4 | 7.41 | 6.59 | 4.01 | 5.03 | 3.26 | 3.41 | 6.43 | 3.96 | 2.42 | 4.35 | 4.09 | |
Puerto Rico($M) | 2.36 | 2.89 | 2.64 | 2.48 | 2.92 | 3.15 | 3.29 | 3.13 | 2.45 | 2.88 | 3.48 | 4.16 | |
Canada($M) | 1.80 | 1.87 | 1.83 | 1.77 | 1.54 | 1.02 | 1.42 | 1.92 | 1.76 | 1.24 | 1.88 | 1.83 | |
Philippines($M) | 0.51 | 0.43 | 0.32 | 0.29 | 217 | 196 | 0.06 | 0 | |||||
11 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-13.
See a number that looks wrong?